Cargando…

Bowel cancer chemoprevention - ready for the clinic?

Detalles Bibliográficos
Autor principal:	Burn, J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3395385/ http://dx.doi.org/10.1186/1897-4287-10-S2-A12

Ejemplares similares

Selecting women for breast cancer chemoprevention and what agents should be used
por: Cuzick, J
Publicado: (2012)

Intraductal assessment to determine response to chemopreventive interventions
por: Sauter, ER
Publicado: (2009)

Chemoprevention with the metabolism modifying drugs dichloroacetate and metformin in Trp53+/- mice
por: Blackburn, AC, et al.
Publicado: (2012)

A genetic journey through cancer: from rarity and family to aspirin and nanowires
por: Burn, J
Publicado: (2012)

Predictive value of readiness, importance, and confidence in ability to change drinking and smoking
por: Bertholet, Nicolas, et al.
Publicado: (2012)

Bowel cancer in a 17 year old: what could be the reason?
por: Bowman, M, et al.
Publicado: (2012)

Pharmacogenetics of tacrolimus: ready for clinical translation?
por: Coto, Eliecer, et al.
Publicado: (2011)

Ultrasonography in pediatric inflammatory bowel diseases
por: Massimetti, Mauro, et al.
Publicado: (2014)

Ultrasound in children and adolescents with inflammatory bowel disease
por: La Seta, Francesco, et al.
Publicado: (2014)

Genes, microbiome, diet and inflammatory bowel disease
por: Baldassano, Robert N
Publicado: (2015)

Thromboembolic tendency (TE) in IBD (inflammatory bowel disease) patients
por: Canero, A, et al.
Publicado: (2010)

Monitoring of electrical activity of small bowel in patients with generalized peritonitis
por: Shvyrev, SL, et al.
Publicado: (1997)

Chemoprevention of Colitis-Associated Dysplasia or Cancer in Inflammatory Bowel Disease
por: Hsiao, Shun-Wen, et al.
Publicado: (2022)

Intestinal Anisakiasis presenting as a small bowel obstruction - Pitfalls in the application of ultrasound
por: Ogata, Masaaki
Publicado: (2012)

Eosinophilic gastroenteritis with gastric and small bowel involvement: successful treatment with oral budesonide
por: Alsayegh, Mohammad, et al.
Publicado: (2012)

Differential expression of mucosal trefoil factors and mucins in pediatric inflammatory bowel diseases
por: Jenke, Andreas C, et al.
Publicado: (2015)

Proceedings of the Indo-U.S. bilateral workshop on accelerating botanicals/biologics agent development research for cancer chemoprevention, treatment, and survival
por: B. Kumar, Nagi, et al.
Publicado: (2013)

Laparoscopic diverting colostomy in the therapeutic management of large bowel obstructions in neoplastic elderly patients
por: Prati, U, et al.
Publicado: (2010)

Traditional Chinese medicine for irritable bowel syndrome: from classic formula to modern medicine development
por: Bian, Zhaoxiang
Publicado: (2012)

EHMTI-0067. Chronic headaches in female patients with irritable bowel syndrome: just another functional condition?
por: Georgescu, D, et al.
Publicado: (2014)

Microbiome analysis in a pediatric cohort of inflammatory bowel disease supports the rational of fecal microbiome therapy
por: Doganci, Aysefa, et al.
Publicado: (2014)

Myeloid regulatory cells: cross talk of innate and adaptive immunity to maintain the intestinal immune homeostasis in inflammatory bowel disease
por: Däbritz, Jan, et al.
Publicado: (2015)

Clinical genetics in cancer prevention
por: Elsakov , Pavel
Publicado: (2012)

Attitudes towards COVID-19 mitigation measures implemented at St Mark's Bowel Cancer Screening Centre: a cross-sectional analysis of survey data from an ethnically diverse region in London
por: Prentice, Andrew, et al.
Publicado: (2021)

Progress in clinical genetics of prostate cancer
por: Cybulski, C, et al.
Publicado: (2011)

Impact of the temporary suspension of the Bowel Screening Wales programme on inequalities during the COVID-19 pandemic: a retrospective register-based study
por: Bright, Diana, et al.
Publicado: (2022)

Chemopreventive Effects of Strawberry and Black Raspberry on Colorectal Cancer in Inflammatory Bowel Disease
por: Chen, Tong, et al.
Publicado: (2019)

Heterogeneity in the clinical phenotype of TP53 mutations in breast cancer patients
por: Alsner, J, et al.
Publicado: (2000)

Cancer Chemoprevention
por: Amin, Amr, et al.
Publicado: (2012)

Clinical and pathological characteristics in patients with BRCA1/2-mutation associated with breast cancer (BC) with a long clinical follow-up
por: Díez, O, et al.
Publicado: (2000)

Dementia Ready: Comparing Approaches for Building Caregiver Readiness and Knowledge of Dementia
por: Lepore, Michael, et al.
Publicado: (2021)

Prevention for colorectal cancer: from basic research to clinical study
por: Fang, Jingyuan
Publicado: (2012)

Epidemiologic and clinical study of skin cancer in the insular regions of Italy
por: d’Alcontres, F Stagno, et al.
Publicado: (2010)

Perspectives in cancer chemoprevention.
por: Stoner, G D, et al.
Publicado: (1997)

Phagocytic activity of monocytes in patients with breast cancer at different clinical stages
por: Arsenijevic, NN, et al.
Publicado: (2001)

Meeting abstracts from the Annual Conference “Clinical Genetics of Cancer 2022”
Publicado: (2023)

Aging as Readiness and Wariness
por: Ekerdt, David
Publicado: (2021)

Prospective clinical trials on correlations between macro-/ microelements and vitamins and cancer risk
por: Lubinski, Jan
Publicado: (2012)

Early experience in a breast and ovarian cancer risk management clinic in Malaysia
por: Taib, NA, et al.
Publicado: (2012)

Metastasis to the thyroid gland as the first clinical manifestation of lung cancer – case report
por: Koziołek, Monika, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_seoonh8sis79qse8cg2181ate7